Borderline personality disorder: Considerations for inclusion in the Massachusetts Parity List of "Biologically-based" disorders

Psychiatric Quarterly

Volumn 82, Issue 2, 2011, Pages 95-112

  Foti, Mary Ellen ^a   Geller, Jeffrey ^b   Guy, Laura S ^b   Gunderson, John G ^c   Palmer, Brian A ^d   Smith, Lisa M ^b  

^a Massachusetts Department of Mental Health   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Biologically based mental illness; Borderline personality disorder; Mental health parity; Mental health policy

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BIOLOGICAL FACTOR; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LAMOTRIGINE; LOXAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANXIETY DISORDER; AUTOMUTILATION; AUTOREGULATION; BACKACHE; BEHAVIOR THERAPY; BIPOLAR DISORDER; BORDERLINE STATE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN SIZE; CHILD ABUSE; CHILD NEGLECT; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EATING DISORDER; EMERGENCY WARD; EMOTION; ENVIRONMENTAL FACTOR; EVOKED RESPONSE; FIBROMYALGIA; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE METABOLISM; HERITABILITY; HIPPOCAMPUS; HOPELESSNESS; HUMAN; HYPERTENSION; IMPULSIVENESS; MAJOR DEPRESSION; MENTAL HEALTH; MOOD DISORDER; NEUROANATOMY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYPHARMACY; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOLOGY; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; SOMATOFORM DISORDER; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TEMPOROMANDIBULAR JOINT DISORDER; TRANSCRANIAL MAGNETIC STIMULATION; UNITED STATES; URINE INCONTINENCE; VENTROMEDIAL PREFRONTAL CORTEX; WORKING MEMORY;

BORDERLINE PERSONALITY DISORDER; BRAIN; COMORBIDITY; DISEASE PROGRESSION; HEALTH POLICY; HUMANS; INSURANCE BENEFITS; MASSACHUSETTS; MENTAL DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 79955720097     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-010-9154-y     Document Type: Review

References (120)

1. Skodol AE, Oldham JM, Bender DS, et al.: Dimensional representations of DSM-IV personality disorders: Relationships to functional impairment. American Journal of Psychiatry 162:1919-1925, 2005
2. Trull TJ, Widiger TA, Lynam DR, et al.: Borderline personality disorder from the perspective of general personality functioning. Journal of Abnormal Psychology 112:193-202, 2003 (Pubitemid 36583173)
3. Sanislow CA, Grilo CM, McGlashan TH: Factor analysis of the DSM-III-R borderline personality disorder criteria in psychiatric inpatients. American Journal of Psychiatry 157:1629-1633, 2000
4. Sanislow CA, Grilo CM, Morey LC, et al.: Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: Findings from the collaborative longitudinal personality disorders study. American Journal of Psychiatry 159:284-290, 2002 (Pubitemid 34126907)
5. Clifton A, Pilkonis PA: Evidence for a single latent class of diagnostic and statistical manual of mental disorders borderline personality pathology. Comprehensive Psychiatry 48:70-78, 2007 (Pubitemid 44826981)
6. Fossati A, Madeddu F, Maffei C: Borderline personality disorder and childhood sexual abuse: A meta-analytic study. Journal of Personal Disorders 13:268-280, 1999 (Pubitemid 29451188)
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text revision. Washington, DC, American Psychiatric Association, 2000
8. Gunderson JG, Links P: Borderline Personality Disorder. In: Gabbard GO (Ed) Treatment of Psychiatric Disorders, 4th edn. Washington, DC, American Psychiatric Press, 2007
9. Zimmerman M, Mattia JI: Differences between clinical and research practices in diagnosing borderline personality disorder. American Journal of Psychiatry 156:1570-1574, 1999 (Pubitemid 29459989)
10. Zimmerman M, Mattia JI: Axis I diagnostic comorbidity and borderline personality disorder. Comprehensive Psychiatry 40:245-252, 1999 (Pubitemid 29319237)
11. Goldberg JF, Garno JL, Callahan AM, et al.: Overdiagnosis of bipolar disorder among substance use disorder patients with mood instability. Journal of Clinical Psychiatry 8:e1-e7, 2008
12. Zimmerman M, Cuggero CJ, Chelminski I, et al.: Psychiatric diagnoses in patients previously over-diagnosed with bipolar disorder. Journal of Clinical Psychiatry 71:6-31, 2010
13. Lenzenweger MF: Epidemiology of personality disorders. Psychiatric Clinics of North America 31:395-403, 2008
14. Torgersen S: Epidemiology. In: Oldham JM, Skodol AE, Bender DS (Eds) Textbook of Personality Disorders. Washington, DC, American Psychiatric Publishing, 2005
15. Torgersen S, Kringlen E, Cramer V: The prevalence of personality disorders in a community sample. Archives of General Psychiatry 58:590-596, 2001 (Pubitemid 32523740)
16. Zlotnick C, Rothschild L, Zimmerman M: The role of gender in the clinical presentation of patients with borderline personality disorder. Journal of Personality Disorders 16:277-282, 2002 (Pubitemid 34734447)
17. Deltito J, Martin L, Riefkohl J, et al.: Do patients with borderline personality disorder belong to the bipolar spectrum? Journal of Affective Disorders 67:221-228, 2001
18. Smith DJ, Muir WJ, Blackwood DH: Is borderline personality disorder part of the bipolar spectrum? Harvard Review of Psychiatry 12:133-139, 2004
19. Koenigsberg HW, Harvey PD, Mitropoulou V, et al.: Characterizing affective instability in borderline personality disorder. American Journal of Psychiatry 159:784-788, 2002 (Pubitemid 34465052)
20. Magill CA: The boundary between borderline personality disorder and bipolar disorder: Current concepts and challenges. Canadian Journal of Psychiatry 49:551-556, 2004
21. Paris J: Borderline or bipolar? Distinguishing borderline personality disorder from bipolar spectrum disorders. Harvard Review of Psychiatry 12:140-145, 2004
22. Zanarini MC, Frankenburg FR, Dubo ED, et al.: Axis II comorbidity of borderline personality disorder. Comprehensive Psychiatry 39:296-302, 1998 (Pubitemid 28425920)
23. Conklin CZ, Westen D: Borderline personality disorder in clinical practice. American Journal of Psychiatry 162:867-875, 2005 (Pubitemid 40676198)
24. Winograd G, Cohen P, Chen H: Adolescent borderline symptoms in the community: Prognosis for functioning over 20 years. Journal of Child Psychological Psychiatry 49:933-941, 2008
25. Zanarini MC, Frankenburg FR, Hennen J: Prediction of the 10-year course of borderline personality disorder. American Journal of Psychiatry 163:827-832, 2006 (Pubitemid 44464530)
26. Gunderson JG, Lyons-Ruth K: BPD's interpersonal hypersensitivity phenotype: A gene-environment-developmental model. Journal of Personality Disorders 22:22-41, 2008 (Pubitemid 351469286)
27. Bolton S, Gunderson JG: Distinguishing borderline personality disorder from bipolar disorder: Differential diagnosis and implications. American Journal of Psychiatry 153:1202-1207, 1996 (Pubitemid 26299842)
28. Black DW, Blum N, Pfohl B, et al.: Suicidal behavior in borderline personality disorder: Prevalence, risk factors, prediction, and prevention. Journal of Personality Disorders 18:226-239, 2004 (Pubitemid 38857552)
29. Oldham JM: Borderline personality disorder and suicidality. American Journal of Psychiatry 163:1, 2006
30. Skodol WE, Gunderson JG, Pfohl B, et al.: The borderline diagnosis I: Psychopathology, comorbidity, and personality structure. Biological Psychiatry 51:936-950, 2002 (Pubitemid 34607710)
31. Oldham JM, Gabbard GO, Goin MK, et al.: Practice Guidelines for the Treatment of Patients with Borderline Personality Disorder. Washington, DC, American Psychiatric Association, 2001
32. Holm AL, Severinsson E: The emotional pain and distress of borderline personality disorder: A review of the literature. International Journal of Mental Health Nursing 17:27-35, 2008
33. Bender DS, Skodol AE, Pagano ME, et al.: Prospective assessment of treatment use by patients with personality disorders. Psychiatric Services 57:254-257, 2006 (Pubitemid 43214474)
34. Zanarini MC, Frankenburg FR, Hennen J, et al.: The McLean study of adult development (MSAD): Overview and implications of the first six years of prospective follow-up. Journal of Personality Disorders 19:505-523, 2005 (Pubitemid 41618524)
35. Grilo CM, Shea MT, Sanislow CA, et al.: Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Journal of Consulting and Clinical Psychology (in press)
36. Zanarini MC, Frankenburg FR, Hennen J, et al.: The longitudinal course of borderline psychopathology: 6-Year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry 160:274-283, 2003 (Pubitemid 41110452)
37. Paris J, Zweig-Frank H: A 27-year follow-up of patients with borderline personality disorders. Psychiatric Quarterly 71:291-307, 2000
38. Paris J: Implications of long-term outcome research for the management of patients with borderline personality disorder. Harvard Review of Psychiatry 10:315-323, 2002
39. Stevenson J, Meares R, Comerford A: Diminished impulsivity in older patients with borderline personality disorder. American Journal of Psychiatry 160:165-166, 2003 (Pubitemid 36042441)
40. Warner MB, Morey LC, Finch JF: The longitudinal relationship of personality traits and disorders. Journal of Abnormal Psychology 113:217-227, 2004 (Pubitemid 38552836)
41. Skodol AE, Pagano ME, Bender DS, et al.: Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychological Medicine 35:443-451, 2004 (Pubitemid 40372482)
42. Torgersen S, Lygren S, Oien PA, et al.: A twin study of personality disorders. Comprehensive Psychiatry 41:416-425, 2000
43. Kendler KS, Greenspan RJ: The nature of genetic influence on behavior: Lessons from "simpler" organisms. American Journal of Psychiatry 163:1683-1694, 2006
44. Ni X, Chan K, Bulgin N, et al.: Association between serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research 40:448-453, 2006 (Pubitemid 43816590)
45. Distel MA, Hottenga JJ, Trull TJ et al.: Chromosome 9: Linkage for borderline personality disorder features. Psychiatric Genetics 18:302-307, 2008
46. White CN, Gunderson JG, Zanarini MC, et al.: Family studies of borderline personality disorder: A review. Harvard Review of Psychiatry 11:8-19, 2003 (Pubitemid 36681916)
47. Silverman JM, Pinkham L, Horvath TB, et al.: Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. American Journal of Psychiatry 148:1378-1385, 1991
48. Zanarini MC, Frankenburg FR, Yong L, et al.: Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. Journal of Personality Disorders 18:439-447, 2004 (Pubitemid 39518505)
49. Trull TJ: Structural relations between borderline personality disorder features and putative etiological correlates. Journal of Abnormal Psychology 110:471-481, 2001
50. Zanarini MC, Yong L, Frankenburg FR, et al.: Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. Journal of Nervous and Mental Disease 190:381-387, 2002 (Pubitemid 34663468)
51. Rinne T, de Kloet ER, Wouters L, et al.: Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotrophin- releasing hormone challenge in female borderline personality disorder subject with a history of sustained childhood abuse. Biological Psychiatry 52:1102-1112, 2002 (Pubitemid 35379967)
52. Battle CL, Shea MT, Johnson DM, et al.: Childhood maltreatment associated with adult personality disorders: Findings from the collaborative longitudinal personality disorders study. Journal of Personality Disorders 18:193-211, 2004 (Pubitemid 38621382)
53. Bandelow B, Krause J, Wedekind D, et al.: Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls. Psychiatry Research 134:169-179, 2005 (Pubitemid 40544284)
54. Fossati A, Maffei C, Bagnato M, et al.: Latent structure analysis of DSM-IV borderline personality disorder criteria. Comprehensive Psychiatry 40:72-79, 1999 (Pubitemid 29037417)
55. Goodman M, Yehuda R: The relationship between psychological trauma and borderline personality disorder. Psychiatric Annals 32:337-346, 2002
56. Paris J: Does childhood trauma cause personality disorders in adults? Canadian Journal of Psychiatry 43:148-153, 1998
57. McGloin JM, Widom CS: Resilience among abused and neglected children grown up. Development and Psychopathology 13:1021-1038, 2001 (Pubitemid 33580430)
58. Schmahl C, Bremner JD: Neuroimaging in borderline personality disorder. Journal of Psychiatric Research 40:419-427, 2006 (Pubitemid 43833310)
59. Völlm B, Richardson P, Stirling J, et al.: Neurobiological substrates of antisocial and borderline personality disorder: Preliminary results of a functional fMRI study. Criminal Behaviour and Mental Health 14:39-54, 2004 (Pubitemid 38102037)
60. Donegan NH, Sanislow CA, Blumberg HP, et al.: Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biological Psychiatry 54:1284-1293, 2003 (Pubitemid 37464873)
61. Oquendo MA, Krunic A, Parsey RV, et al.: Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Neuropsychopharmacology 30:1163-1172, 2005 (Pubitemid 40720975)
62. Juengling FD, Schmahl C, Hesslinger B, et al.: Positron emission tomography in female patients with borderline personality disorder. Journal of Psychiatric Research 37:109-115, 2003 (Pubitemid 36808473)
63. 11C] methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. The American Journal of Psychiatry 158:775-782, 2001
64. Stevens A, Burkhardt M, Hautzinger M, et al.: Borderline personality disorder: An impaired visual perception and working memory. Psychiatry Research 125:257-267, 2003 (Pubitemid 38393789)
65. Coccaro EF, Siever LJ, Klar HM, et al.: Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry 46:587-599, 1989
66. Joyce PR, McHugh PC, McKenzie JM, et al.: A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. They Psychological Medicine 36:807-813, 2006 (Pubitemid 43744774)
67. Austin MA, Riniolo TC, Porges SW: Borderline personality disorder and emotion regulation: Insights from the Polyvagal Theory. They Brain and Cognition 65:69-76, 2007 (Pubitemid 47391119)
68. Barnow S, Völker KA, Möller B, et al.: The neurophysiological correlates of borderline personality disorder: A transcranial magnetic stimulation study. Biological Psychiatry 65:313-318, 2009
69. Oldham JM: Guideline Watch: A Practice Guideline for the Treatment of Patients with Borderline Personality Disorder. Washington, DC, American Psychiatric Association, 2005. http://www. psychiatryonline.com/pracGuide/ pracGuideTopic-13.aspx
70. Linehan MM: Cognitive Behavioral Treatment of Borderline Personality Disorder. New York, Guilford Press, 1993
71. van den Bosch LM, Verheul R, Schippers GM, et al.: Dialectical behavior therapy of borderline patients with and without substance use problems: Implementation and longterm effects. Addictive Behaviors 27:911-923, 2002 (Pubitemid 36158754)
72. Linehan MM, Dimeff LA, Reynolds SK, et al.: Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence 67:13-26, 2002 (Pubitemid 34615925)
73. Harned MS, Chapman AL, Dexter-Mazza ET, et al.: Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: A 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. Journal of Consulting and Clinical Psychology 76:1068-1075, 2008
74. Bohus M, Haaf B, Simms T, Limberger MF, et al.: Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: A controlled trial. Behavior Research and Therapy 42:487-499, 2004 (Pubitemid 38368900)
75. Koons C, Robins CJ, Tweed JL, et al.: Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behavior Therapy 32:371-390, 2001 (Pubitemid 32995880)
76. Verheul R, van den Bosch LM, Koeter MW, et al.: Dialectical behaviour therapy for women with borderline personality disorder: 12-Month, randomised clinical trial in the Netherlands. British Journal of Psychiatry 182:135-140, 2003 (Pubitemid 36177236)
77. Brown GK, Newman CF, Charlesworth SE: An open clinical trial of cognitive therapy for borderline personality disorder. Journal of Personality Disorder 18:257-271, 2004 (Pubitemid 38857555)
78. Blum N, Pfohl B, John DS, et al.: STEPPS: A cognitive-behavioral systems-based group treatment for outpatients with borderline personality disorder - a preliminary report. Comprehensive Psychiatry 43:301-310, 2002 (Pubitemid 34774349)
79. Bateman A, Fonagy P: Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial. American Journal of Psychiatry 156:1563-1569, 1999 (Pubitemid 29459988)
80. Bateman A, Fonagy P: Treatment of BPD with psychoanalytically oriented partial hospitalization: An 18-month follow-up. American Journal of Psychiatry 158:36-42, 2001 (Pubitemid 32047244)
81. Bateman A, Fonagy P: Eight-year follow-up of patients treated for borderline personality disorder: Mentalization-based treatment versus treatment as usual. American Journal of Psychiatry 165:631-638, 2008 (Pubitemid 351705341)
82. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF: Evaluating three treatments for borderline personality disorder: A multiwave study. American Journal of Psychiatry 164:922-928, 2007 (Pubitemid 46972908)
83. Giesen-Bloo J, van Dyck R, Spinhoven P, et al.: Outpatient psychotherapy for borderline personality disorder: Randomized trial of schema-focused therapy vs. transference-focused psychotherapy. Archives of General Psychiatry 63:649-658, 2006 (Pubitemid 43848296)
84. McMain SF, Links PS, Gnam WH et al.: A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry 166:1365-1374, 2009
85. Bateman A, Fonagy P: Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry 166:1355-1364, 2009
86. American Psychiatric Association: Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2002. American Psychiatric Association, Washington, DC, 2002
87. Gunderson JG, Morey LC, Stout RL, et al.: Major depressive disorder and borderline personality disorder revisited: Longitudinal interactions. Journal of Clinical Psychiatry 65:1049-1056, 2004
88. Neves FS, Malloy-Diniz LF, Corrêa H: Suicidal behavior in bipolar disorder: What is the influence of psychiatric comorbidities? Journal of Clinical Psychiatry 70:13-18, 2009
89. Frankenburg FR, Zanarini MC: The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. Journal of Clinical Psychiatry 65:1660-1665, 2004
90. American Psychiatric Association: Practice Guideline for the Treatment of Patients with Borderline Personality Disorder. American Journal of Psychiatry 158(Suppl):1-52, 2001
91. Herpertz SC, Zanarini MC, Schulz CS, et al.: WFSBP task force on personality disorders: World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World Journal of Biological Psychiatry 8:212-244, 2007
92. Sansone RA, Rytwinski D, Gaither GA: Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic. Comprehensive Psychiatry 44:454-458, 2003 (Pubitemid 37420712)
93. Pascual JC, Córcoles D, Castaño J, et al.: Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service. Psychiatric Services 58:1199-1204, 2007 (Pubitemid 47507960)
94. Oldham JM, Bender DS, Skodol AE, et al.: Testing an APA practice guideline: Symptom-targeted medication utilization for patients with borderline personality disorder. Journal of Psychiatric Practice 10:156-161, 2004
95. Abraham PF, Calabrese JR: Evidenced-based pharmacologic treatment of borderline personality disorder: A shift from SSRIs to anticonvulsants and atypical antipsychotics? Journal of Affective Disorders 111:21-30, 2008
96. Ingenhoven T, Lafay P, Rinne T, et al.: Effectiveness of pharmacotherapy for severe personality disorders: Meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry 71:14-25, 2010
97. Bellino S, Paradiso E, Bogetto F: Efficacy and tolerability of pharmacotherapies for borderline personality disorder. CNS Drugs 22:671-692, 2008 (Pubitemid 351950098)
98. Paris, J: Clinical trials of treatment for personality disorders. Psychiatric Clinics of North America 31:517-526, 2008
99. Soloff PH: Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America 23:169-192, 2000
100. Zanarini MC, Frankenburg FR, Parachini, EA: A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. Journal of Clinical Psychiatry 65:903-907, 2004
101. Soler J, Pascual JC, Campins J, et al.: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. American Journal of Psychiatry 162:1221-1224, 2005 (Pubitemid 40770712)
102. Roepke S, Merkl A, Dams A, et al.: Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: An open label trial. Pharmacopsychiatry 41:176-181, 2008
103. Nickel MK, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo-controlled study. American Journal of Psychiatry 163:833-838, 2006 (Pubitemid 44464531)
104. Díaz-Marsá M, Galian M, Montes A, et al.: Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report. Actas Espanolas de Psiquiatria 36:70-74, 2008
105. Sansone RA, Sansone LA, Wiederman MW: The comorbidity, relationship and treatment implications of borderline personality and obesity. Journal of Psychosomatic Research 43:541-543, 1997 (Pubitemid 27487546)
106. Sansone RA, Schumacher D, Wiederman MW, et al.: The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients. Eating Behaviors 9:197-202, 2008 (Pubitemid 351336919)
107. Sansone RA, Wiederman MW, Sansone LA: The prevalence of borderline personality disorder among individuals with obesity: A critical review of the literature. Eating Behaviors 1:93-104, 2000
108. Frankenburg FR, Zanarini MC: Obesity and obesity-related illnesses in borderline patients. Journal of Personality Disorders 20:71-80, 2006
109. Links PS, Steiner M, Boiago I, et al.: Lithium therapy for borderline patients: Preliminary findings. Journal of Personality Disorders 4:173-181, 1990 (Pubitemid 20339898)
110. Hollander E, Swann AC, Coccaro EF, et al.: Impact of trait impulsivity and aggression on divalproex versus placebo response in borderline personality disorder. American Journal of Psychiatry 162:621-624, 2005 (Pubitemid 40343936)
111. Weinstein W, Jamison KL: Retrospective case review of Lamotrigine use for affective instability of borderline personality disorder. CNS Spectrums 12:207-210, 2007 (Pubitemid 46555889)
112. Zanarini MC: Update on pharmacotherapy of borderline personality disorder. Current Psychiatry Reports 6:66-70, 2004
113. Zimmerman DJ, Choi-Kain LW: The hypothalamic-pituitary-adrenal axis in borderline personality disorder: A review. Harvard Review of Psychiatry 17:167-183, 2009
114. New AS, Triebwasser J, Charney DS: Review: The case for shifting borderline personality disorder to Axis I. Biological Psychiatry 64:653-659, 2008
115. Gunderson JG: Borderline personality disorder: Ontogeny of a diagnosis. American Journal of Psychiatry 166:530-539, 2009
116. Linehan MM, Heard HL: Borderline Personality Disorder: Costs, Course and Treatment Outcomes In: Miller N, Magruder K (Eds) The Cost-Effectiveness of Psychotherapy: A Guide for Practitioners, Researchers and Policy Makers. New York, Oxford Press, 1999
117. Bateman A, Fonagy P: Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. American Journal of Psychiatry 160:169-171, 2003 (Pubitemid 36042443)
118. Livesley WJ: Research trends and directions in the study of personality disorder. Psychiatric Clinics of North America 31:545-559, 2008
119. Olfson M, Marcus SC, Pincus HA: Trends in office-based psychiatric practice. American Journal of Psychiatry 156:451-457, 1999 (Pubitemid 29124169)
120. Geller JL, Brandzel M: Addressing the borderline's repetitive misuse of the state hospital. Psychiatric Quarterly 55:275-278, 1983 (Pubitemid 14012300)